INTELLIA THERAPEUTICS INC. - COMMON STOCK

10.20

10-January-25 16:45:00

15 minutes delayed

Stocks

-1.82

-15.14%

Today's range

9.93 - 11.43

ISIN

N/A

Source

NASDAQ

Intellia Therapeutics Presents Preclinical Proof of Concept for CRISPR-based In Vivo Editing of Bone Marrow at Keystone eSymposium

10 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results

25 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2020 Earnings and Company Updates

18 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Intellia Therapeutics Highlights Strategic Priorities and Anticipated Development Milestones for 2021

07 Jan 2021 07:30:00 By Nasdaq GlobeNewswire

<<
<
4
5
6
7
8
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.